Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease - authors' reply.
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. yaroslava.zhulina@regionorebrolan.se.
Y
Y
Zhulina
Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.|Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Y
Y
Cao
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.|Department of Medical Sciences, Gastroenterology Research Group, Uppsala University, Uppsala, Sweden.
K
K
Amcoff
Department of Medical Sciences, Gastroenterology Research Group, Uppsala University, Uppsala, Sweden.
M
M
Carlson
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
C
C
Tysk
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
J
J
Halfvarson
D015415:Biomarkers; D005243:Feces; D006801:Humans; D015212:Inflammatory Bowel Diseases; D039841:Leukocyte L1 Antigen Complex; D012008:Recurrence
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex